Valeant Pharmaceuticals International Inc. is in talks to sell its Salix stomach-drug business to Japanese pharmaceutical company Takeda Pharmaceutical Co., according to people familiar with the matter.
The deal could potentially raise as much as $10 billion for the indebted drugmaker, the people said, asking not to be identified because the discussions are private.
There is no guarantee that the discussions will lead to a deal, they said.
Valeant is working with investment bank Morgan Stanley on the sale, they added. News of the talks was first reported by the Wall Street Journal.
More from Star Tribune
More from Star Tribune
More from Star Tribune
More from Star Tribune
More from Star Tribune
More from Star Tribune
More from Star Tribune
More From Star Tribune
More From Business
Business
Owner of exploded Michigan building arrested at airport while trying to leave US, authorities say
The owner of a suburban Detroit business that caught fire and exploded, killing a man, was arrested at a New York airport as he was preparing to depart for Hong Kong on a one-way ticket, authorities said Friday.
Business
JPMorgan's Dimon hopes for soft landing for US economy but says stagflation is a possible scenario
JPMorgan Chase CEO Jamie Dimon says he's hopeful the Federal Reserve can bring down inflation without causing a recession but wouldn't rule out more troubling possibilities, such as stagflation.
Business
Fed's preferred inflation gauge shows price pressures stayed elevated last month
A measure of inflation closely tracked by the Federal Reserve remained uncomfortably high in March, likely reinforcing the Fed's reluctance to cut interest rates anytime soon and underscoring a burden for President Joe Biden's re-election bid.
Business
G/O Media sells satirical news site the Onion to group of digital media veterans
New owner Global Tetrahedron is named after a sinister fictional company in the book "Our Dumb Century."
Business
Closing prices for crude oil, gold and other commodities
Benchmark U.S. crude oil for June delivery rose 28 cents to $83.85 per barrel Friday. Brent crude for June delivery rose 49 cents to $89.50 per barrel.